Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
Metabolic Health After 40: What Perimenopause and Menopause Mean for Weight Management
07:00am, Thursday, 11'th Jun 2026
OPTAVIA's clinical program reduces visceral fat 14% and retains 98% lean mass, directly addressing the metabolic impact of perimenopause and menopause.
What Science-Backed Subscription Health Programs Measure Differently
07:00am, Thursday, 11'th Jun 2026
The weight loss and weight management market was valued at $31.07 billion in 2025 A program can describe its results as clinically meaningful without specifying what was measured, how it was measure
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound?
12:30pm, Wednesday, 03'rd Jun 2026
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year?
10:41am, Tuesday, 02'nd Jun 2026
Here is how Medifast (MED) and New York Times Co. (NYT) have performed compared to their sector so far this year.
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer
04:05pm, Tuesday, 26'th May 2026
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced that its Board of Directors has formally appointed Nicholas Johnson as Chief Executive Officer, effective June 1, 2026. Johnson w
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes
07:00am, Thursday, 21'st May 2026
70% of users discontinued use of lifestyle behavior and health apps within the first 100 days (Kidman PG, et al., 2024) Early weight loss at week four is a strong predictor of clinically relevant outc
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
07:00am, Thursday, 21'st May 2026
A randomized controlled trial published in Obesity Science & Practice found that clients on the OPTAVIA Optimal Weight 5 & 1 Plan® who worked with a coach lost significantly more weight and fat than
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation
01:00pm, Friday, 15'th May 2026
Body composition, specifically visceral fat levels and lean mass, plays a meaningful role in long-term metabolic health (Serra MC, et al., 2019) Structured plans, habit building, and dedicated coach s
Peer-Reviewed Research Is Redefining Weight Loss Program Standards
01:00pm, Friday, 15'th May 2026
The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the category Randomized controlled trials control f
Why Medifast's $15 Cash Per Share Makes It A Strong Buy
12:23am, Wednesday, 13'th May 2026
Medifast trades below net cash value, with $15 per share in cash versus a $12.60 share price, creating a compelling value floor. Coach productivity surged 19% YoY to $5,432 per coach, signaling early
Medifast: Worth Putting On A Watchlist
06:58am, Tuesday, 12'th May 2026
Medifast has continued to report concerning financials. A shrinking coach network lowers revenues, and costs remain too high. A turnaround can't be written off quite yet. MED's coach productivity has
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
03:00pm, Tuesday, 05'th May 2026
MED beats first-quarter estimates despite steep revenue declines, while stronger coach productivity and a new product launch support recovery hopes.
Medifast, Inc. (MED) Q1 2026 Earnings Call Transcript
06:53pm, Monday, 04'th May 2026
Medifast, Inc. (MED) Q1 2026 Earnings Call Transcript
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates
06:50pm, Monday, 04'th May 2026
Medifast (MED) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to a loss of $0.11 per share a year ago.
Medifast Announces First Quarter 2026 Financial Results
04:05pm, Monday, 04'th May 2026
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the first quarter en
